Showing results (61-70 of 318) with videos related to
Sort By:
Pageof 32
Pharmaceutical Research|March 24, 2005
Metformin transport by renal basolateral organic cation transporter hOCT2Naoko Kimura, Masahiro Okuda, Ken-ichi InuiJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 19, 2010
Cerebrospinal fluid concentration of erlotinib and its active metabolite OSI-420 in patients with central nervous system metastases of non-small cell lung cancerYosuke Togashi, Katsuhiro Masago, Masahide Fukudo, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 9, 2020
Inhibitory effects of vandetanib on creatinine transport via renal organic cation transporter OCT2Yuko Tanihara, Satohiro Masuda, Ken-Ichi InuiDrug Metabolism and Pharmacokinetics|October 31, 2006
Interactions of fluoroquinolone antibacterials, DX-619 and levofloxacin, with creatinine transport by renal organic cation transporter hOCT2Masahiro Okuda, Naoko Kimura, Ken-ichi InuiDrug Metabolism and Pharmacokinetics|December 25, 2004
Rat renal organic anion transporter rOAT1 mediates transport of urinary-excreted cephalosporins, but not of biliary-excreted cefoperazoneYuichi Uwai, Hideyuki Saito, Ken-Ichi InuiPharmaceutical Research|November 16, 2007
Thyroid hormone regulates the expression and function of P-glycoprotein in Caco-2 cellsNaoki Nishio, Toshiya Katsura, Ken-ichi InuiDrug Metabolism and Pharmacokinetics|December 27, 2007
Decreased renal accumulation and toxicity of a new VCM formulation in rats with chronic renal failureNaoko Hodoshima, Satohiro Masuda, Ken-Ichi InuiCase Reports in Oncology|August 27, 2010
Good Clinical Response to Erlotinib in a Non-Small Cell Lung Cancer Patient Harboring Multiple Brain Metastases and a Double Active Somatic Epidermal Growth Factor Gene MutationKatsuhiro Masago, Yosuke Togashi, Masahide Fukudo, et al.International Journal of Clinical Oncology|April 25, 2009
UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patientsMasahide Onoue, Tomohiro Terada, Masahiko Kobayashi, et al.Pharmacogenetics and Genomics|December 18, 2009
Heterozygous variants of multidrug and toxin extrusions (MATE1 and MATE2-K) have little influence on the disposition of metformin in diabetic patientsKana Toyama, Atsushi Yonezawa, Masahiro Tsuda, et al.Pageof 32